Susan Shiff Ph.D.
CIK: 0001811463
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TVRD
Tvardi Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Shiff Susan Ph.D.
Shiff Susan Ph.D. (SEC CIK 0001811463) files insider reports with the SEC as Director of Tvardi Therapeutics, Inc. (TVRD).
Signal8 holds 2 ownership filings by Shiff Susan Ph.D., all Form 4s, filed between Apr 21, 2025 and Jun 11, 2026. Those filings report 2 transactions, from Apr 17, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shiff Susan Ph.D.'s filings is in SUGAR LAND, TX.
Recent filings by Shiff Susan Ph.D.
Other insiders filing for Tvardi Therapeutics, Inc. (TVRD)
- Smith Cynthia, Director
- Shah Sujal, Director
- HALL WALLACE L JR, Director
- WYZGA MICHAEL S, Director
- O'Brien Stephen Paul, Principal Accounting Officer
- Conn Avi Daniel, Chief Financial Officer